FedInvent™ Patents
Patent Details for Tuesday, July 22, 2008
This page was updated on Monday, March 27, 2023 at 12:58 AM GMT
Department of Defense (DOD)
| US 07401505 | Schultz et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Ronald Schultz (Ridgecrest, California); Warren Kendrick Jaul (Ridgecrest, California) |
| ABSTRACT | The invention disclosed herein provides a subsonic wind tunnel capable for accurately maintaining a desired Mach number, pressure and temperature for use in aerothermal testing of materials. The invention allows the Mach number to be precisely controlled in the test section of the wind tunnel by employing a restricted outlet acting as a sonic throat for the wind tunnel. In the preferred embodiment, the restricted outlet is constructed to be variable in cross sectional area allowing a range of Mach numbers to be tested. The variable outlet is varied during the operation of the wind tunnel so that an actual trajectory with changing Mach numbers, pressure, and temperature is simulated. |
| FILED | Tuesday, January 09, 2007 |
| APPL NO | 11/653478 |
| ART UNIT | 2855 — Printing/Measuring and Testing |
| CURRENT CPC | Measuring and testing 073/147 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07401515 | Weber |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Honeywell International Inc. (Morristown, New Jersey) |
| INVENTOR(S) | Mark W. Weber (Zimmerman, Minnesota) |
| ABSTRACT | Adaptive circuits and methods for reducing vibration-induced bias errors in inertial sensors. An adaptive circuit for reducing vibration or shock induced errors in an inertial sensor having a proof mass and sense electrode may include a sense bias voltage source, a charge amplifier, a device for detecting and/or anticipating an external vibration or shock on the inertial sensor, and a device for selectively dampening the proof masses and/or adjusting the gain sensitivity of the charge amplifier in response to an external vibration or shock on the inertial sensor. A dampening resistive element may be provided to dampen the proof mass motion in response to an external vibration or shock on the inertial sensor. Alternatively, or in addition, the gain sensitivity of the rate signal outputted by the charge amplifier can be adjusted in response to an external vibration or shock on the inertial sensor. During operation, the dampening and/or gain sensitivity can be adjusted to prevent signal saturation or clipping from occurring in the sense electronics, allowing the inertial sensor to continue functioning during periods of vibration or shock. |
| FILED | Tuesday, March 28, 2006 |
| APPL NO | 11/277686 |
| ART UNIT | 2856 — Printing/Measuring and Testing |
| CURRENT CPC | Measuring and testing 073/504.120 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07401565 | Nixon et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Laurence Nixon (Port Hueneme, California); William Seelig (Rockville, Maryland); Stephen Slaughter (Costa Mesa, California) |
| ABSTRACT | The port security barrier includes multiple barrier float assemblies connected to one another to form a barrier to stop, delay and discourage attacks by high speed boats of sixty five feet or less in length on high valued waterfront assets such as ports and docking facilities. The port security barrier includes multiple barrier floats coupled to one another by flange connectors. Each barrier float assembly also has a capture nylon net which is used to capture the high speeds and prevent an intrusion into restricted waters. |
| FILED | Monday, November 06, 2006 |
| APPL NO | 11/602429 |
| ART UNIT | 3641 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review |
| CURRENT CPC | Ships 114/241 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07401643 | Queheillalt et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Virginia Patent Foundation (Charlottesville, Virginia) |
| INVENTOR(S) | Douglas T. Queheillalt (Charlottesville, Virginia); Haydn N. G. Wadley (Keswick, Virginia); Yasushi Katsumi (Charlottesville, Virginia) |
| ABSTRACT | A method and an apparatus for the efficient transfer of heat utilizing micro heat pipes that include a cellular foam or interconnected cellular/truss network having hollow ligaments. A predetermined fraction of the internal volume of the hollow ligaments is filled with a carefully chosen working fluid, and the ends of the hollow ligaments are sealed. In operation, the working fluid evaporates in the region of high heat flux and condenses in regions of lower temperature, resulting in the transfer or redistribution of the fluid's latent heat of vaporization. For open cell foams and interconnected networks, a second fluid flowing through the open cells, separate from the working fluid but also in thermal contact with the hollow ligaments, assists in the transfer of heat from the foam and networks. |
| FILED | Monday, July 16, 2001 |
| APPL NO | 10/333004 |
| ART UNIT | 3744 — Aeronautics, Agriculture, Fishing, Trapping, Vermin Destroying, Plant and Animal Husbandry, Weaponry, Nuclear Systems, and License and Review |
| CURRENT CPC | Heat exchange 165/104.210 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07401682 | Proscia et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | United Technologies Corporation (Hartford, Connecticut) |
| INVENTOR(S) | William Proscia (Marlborough, Connecticut); Christopher D. Jones (Thomaston, Connecticut) |
| ABSTRACT | An acoustic liner 20 includes a remote panel 26, a perforated proximate panel 22 transversely spaced from the remote panel and one or more partitions 32 spanning across the space between the panels. At least one baffle 44 cooperates with the partitions to define a resonator chamber 34b and an associated neck 56 for establishing communication between the resonator chamber and a fluid stream G flowing past the proximate panel. |
| FILED | Wednesday, August 10, 2005 |
| APPL NO | 11/200563 |
| ART UNIT | 2837 — Electrical Circuits and Systems |
| CURRENT CPC | Acoustics 181/290 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07401865 | Shaw |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Delphi Technologies, Inc. (Troy, Michigan) |
| INVENTOR(S) | Schuyler S. Shaw (Dayton, Ohio) |
| ABSTRACT | A torsion pedal feel emulator assembly for a motor vehicle and a method of operating the same. The assembly includes a pedal member for receiving an applied pedal force. A torsion member is operably attached to the pedal member. A portion of the torsion member is positioned adjacent a reaction surface. The torsion member rotates as a result of the applied pedal force, and a dynamic reaction force is generated against the applied pedal force. A pivot is operably attached to the torsion member and the motor vehicle. The method includes receiving an applied pedal force. A torsion member is rotated as a result of the applied pedal force. A dynamic reaction force is generated against the applied pedal force as a result of the torsion member rotation. |
| FILED | Wednesday, March 12, 2003 |
| APPL NO | 10/387013 |
| ART UNIT | 3683 — Business Methods - Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation |
| CURRENT CPC | Fluid-pressure and analogous brake systems 33/3 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402052 | Hougham et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | International Business Machines Corporation (Armonk, New York) |
| INVENTOR(S) | Gareth G. Hougham (Ossining, New York); Brian S. Beaman (Cary, North Carolina); Evan G. Colgan (Chestnut Ridge, New York); Paul W. Coteus (Yorktown Heights, New York); Stefano S. Oggioni (Besana in Brianza, Italy); Enrique Vargas (Bronx, New York) |
| ABSTRACT | A land grid array (LGA) interposer structure, including an electrically insulating carrier plane, and at least one interposer mounted on a first surface of said carrier plane. The interposer possesses a hemi-toroidal configuration in transverse cross-section and is constituted of a dielectric elastomeric material. A plurality of electrically-conductive elements are arranged about the surface of the at least one hemi-toroidal interposer and extend radically inwardly and downwardly from an uppermost end thereof into electrical contact with at least one component located on an opposite side of the electrically insulating carrier plane. Provided is also a method of producing the land grid array interposer structure. |
| FILED | Monday, October 01, 2007 |
| APPL NO | 11/865305 |
| ART UNIT | 2839 — Business Methods - Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation |
| CURRENT CPC | Electrical connectors 439/66 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402298 | Kinch et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Purdue Research Foundation (West LaFayette, Indiana); SmithKline Beecham Corporation (Philadelphia, Pennsylvania) |
| INVENTOR(S) | Michael Scott Kinch (Laytonsville, Maryland); Kelly Carles-Kinch (Laytonsville, Maryland); Katherine E Kilpatrick (Durham, North Carolina) |
| ABSTRACT | The invention provides a monoclonal antibody, a fragment thereof, or a molecular complex thereof that binds to an extracellular domain of an EphA2 receptor molecule, wherein binding of the monoclonal antibody or fragment thereof to the EphA2 receptor molecule present in the membrane of a cancer cell favorably alters activity of the EphA2 receptor molecule. The invention further relates to methods of making and using the monoclonal antibodies, fragments, and molecular complexes regarding the same. The monoclonal antibodies of the present invention target the extracellular domain of EphA2 and operate to redirect the function of EphA2 to selectively block the growth and invasiveness of metastatic cells. The invention thus makes possible therapeutic strategies that optimally target metastatic cells while preventing collateral damage to normal tissues. |
| FILED | Thursday, December 02, 2004 |
| APPL NO | 11/004005 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/9.340 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402531 | Kuekes et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Hewlett-Packard Development Company, L.P. (Houston, Texas) |
| INVENTOR(S) | Philip J. Kuekes (Palo Alto, California); Theodore I. Kamins (Palo Alto, California) |
| ABSTRACT | A method for selectively controlling lengths of nanowires in a substantially non-uniform array of nanowires includes establishing at least two different catalyzing nanoparticles on a substrate. A nanowire from each of the at least two different catalyzing nanoparticles is substantially simultaneously grown. At least one of the nanowires has a length different from that of at least another of the nanowires. |
| FILED | Friday, December 09, 2005 |
| APPL NO | 11/297900 |
| ART UNIT | 1792 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/755 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402678 | Benson et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | 3M Innovative Properties Company (St. Paul, Minnesota) |
| INVENTOR(S) | Karl E. Benson (St. Paul, Minnesota); Cary A. Kipke (Woodbury, Minnesota); Brinda B. Lakshmi (Woodbury, Minnesota); Charles M. Leir (Falcon Heights, Minnesota); George G. I. Moore (Afton, Minnesota); Rahul Shah (Woodbury, Minnesota) |
| ABSTRACT | Multifunctional compounds having acylsulfonamide amine-reactive groups are described that can be used for the capture of amine containing materials. |
| FILED | Friday, December 17, 2004 |
| APPL NO | 11/015543 |
| ART UNIT | 1626 — Organic Chemistry |
| CURRENT CPC | Organic compounds 548/213 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402679 | Irvin et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | David J. Irvin (Ridgecrest, California); Mark H. Mason (Inyokern, California); Stephen Fallis (Ridgecrest, California); Andrew Chafin (Ridgecrest, California); Richard Hollins (Ridgecrest, California) |
| ABSTRACT | A process for making energetic urethane cured binders by making poly-tetrazoles to produce multi-functional tetrazole polyols for producing tetrazole base polymers. Embodiments of the present invention relate generally to a process for preparation of a monomer including reacting an effective amount of nitrile(s) with inorganic azide and a divalent zinc salt in a first solvent, cooling to room temperature producing poly tetrazole purifying the poly tetrazole by recrystallization or precipitation in a second solvent, and reacting an effective amount of the purified poly-tetrazole with a third solvent, a soluble reversible or non-reversible base, and 2-chloro-ethanol, cooling to room temperature producing tetrazole polyol. Embodiments of the present invention further include the monomers produced by the processes described herein. |
| FILED | Friday, May 27, 2005 |
| APPL NO | 11/151178 |
| ART UNIT | 1626 — Organic Chemistry |
| CURRENT CPC | Organic compounds 548/250 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402744 | Wiedemer |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Air Force (Washington, District of Columbia) |
| INVENTOR(S) | Matthew Wiedemer (Beaverton, Oregon) |
| ABSTRACT | Method for providing steganography in MIDI files. Present invention provides list steganography algorithms and methods for their application to MIDI files. Present invention further provides a 300% increase in average encoding rate and better implementation of stego-keys is achieved over previous MIDI steganography methods. |
| FILED | Friday, June 10, 2005 |
| APPL NO | 11/151175 |
| ART UNIT | 2837 — Electrical Circuits and Systems |
| CURRENT CPC | Music 084/645 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402805 | Savoie et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Matthew J. Savoie (Mansfield, Massachusetts); Michael J. Forbes (Hanover, Maine) |
| ABSTRACT | A device and method of use for measurement of in-situ bioluminescence generally comprising an acoustical pulse generator, a detector chamber, a lens assembly and a photomultiplier tube. The generator comprises transducers which can generate acoustical energy in the object field of the device. The acoustical energy provides a stimulus of aquatic organisms within the object field (typically an aqueous volume) to produce the bioluminescence. The generator is positioned outside of the detector chamber and the photomultiplier tube and lens assembly are mounted within the chamber. The lens assembly restricts light to the photomultiplier tube of that bioluminescence light originating only from the volume. The photomultiplier tube detects the bioluminescence generated by any aquatic organisms in a captured volume or if a changing measurement occurs by water flow in the volume. The output of the photomultiplier tube is provided to a controller to be analyzed. |
| FILED | Monday, August 22, 2005 |
| APPL NO | 11/208126 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Radiant energy 250/361.C00 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402849 | Liu et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Board of Trustees of the University of Illinois (Urbana, Illinois) |
| INVENTOR(S) | Chang Liu (Champaign, Illinois); Ming Zhang (Urbana, Illinois); David Andrew Bullen (Pittsburgh, Pennsylvania) |
| ABSTRACT | A microfabricated probe array for nanolithography and process for designing and fabricating the probe array. The probe array consists of individual probes that can be moved independently using thermal bimetallic actuation or electrostatic actuation methods. The probe array can be used to produce traces of diffusively transferred chemicals on the substrate with sub-1 micrometer resolution, and can function as an arrayed scanning probe microscope for subsequent reading and variation of transferred patterns. |
| FILED | Monday, March 07, 2005 |
| APPL NO | 11/073938 |
| ART UNIT | 2892 — Semiconductors/Memory |
| CURRENT CPC | Active solid-state devices 257/226 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403113 | Moon et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | California Institute of Technology (Pasadena, California); HRL Laboratories, LLC. (Malibu, California); The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Jeong-Sun Moon (Moorpark, California); Nicholas Prokopuk (Ridgecrest, California); Kyung-Ah Son (Moorpark, California) |
| ABSTRACT | A system for detecting chemical/biological substances and a detection method. The system comprises a plurality of sensing units or nodes and a radiofrequency link. Each unit has several sensors with different sensing curves. Each sensor is able to transmit information related to the sensed substance on a specific frequency. The sensors preferably comprise AlGaN/GaN high electron mobility transistors. |
| FILED | Wednesday, May 11, 2005 |
| APPL NO | 11/128110 |
| ART UNIT | 2612 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory |
| CURRENT CPC | Communications: Electrical 340/539.220 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403326 | Shaw et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Brandon Shaw (Woodbridge, Virginia); Jasbinder S. Sanghera (Ashburn, Virginia); Ishwar D. Aggarwal (Fairfax Station, Virginia); Peter A. Thielen (Cerritos, California) |
| ABSTRACT | This invention pertains to a scene projection system and a method for projecting a scene that can simulate light temperature of above 2000 K. The system comprises of a light source part for generating light at a lower wavelength; a means part for individually controlling dynamic range, contrast, brightness, temporal characteristics and temporal dynamics of the light; a rare earth doped fiber part that re-emits the output light at a higher wavelength; and a means part for conveying light between its parts. The method comprises steps of generating light at a lower wavelength; individually controlling temporal characteristics, temporal dynamics, brightness and contrast of the light; passing the light through a rare earth-doped fiber; and re-emitting the light at a higher wavelength. |
| FILED | Friday, December 02, 2005 |
| APPL NO | 11/296714 |
| ART UNIT | 2874 — Optics |
| CURRENT CPC | Optical: Systems and elements 359/326 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403338 | Wu et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | President and Fellows of Harvard College (Cambridge, Massachusetts) |
| INVENTOR(S) | Ming-Hsien Wu (Kaohsiung, Taiwan); George M. Whitesides (Newton, Massachusetts); Kateri E. Paul (Everett, Massachusetts) |
| ABSTRACT | Methods and systems for effecting responses on surfaces utilizing microlens arrays including microoptical components embedded or supported by a support element and positioned from the surface at a distance essentially equal to the image distance of the microoptical component with spacer elements are disclosed. Microlens arrays can be used to manipulate incident energy or radiation having a distribution in characteristic property(s) defining an object pattern to form a corresponding image pattern on a substrate surface. The energy can be light having a pattern or a specific wavelength, intensity or polarization or coherence alignment. The image pattern can have features of order 100 nm in size or less produced from corresponding object patterns having features in the order millimeters. The size of the object pattern can be reduced by the microlens arrays described by a factor of 100 or more using a single step process to form the image patterns. |
| FILED | Tuesday, January 17, 2006 |
| APPL NO | 11/333764 |
| ART UNIT | 2873 — Optics |
| CURRENT CPC | Optical: Systems and elements 359/651 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403509 | Giannakis et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Regents of the University of Minnesota (Minneapolis, Minnesota) |
| INVENTOR(S) | Georgios B. Giannakis (Minnetonka, Minnesota); Shengli Zhou (Ashford, Connecticut) |
| ABSTRACT | Techniques are described for performing block equalization on a received wireless communication signal formed according to interleaved chips generated from sub-blocks of symbols. For example, a one-step block equalization process is described which produces estimates of the information-bearing symbols from a wireless communication signal received from two or more transmitters in a soft handoff environment. The techniques provide improved performance in high load, soft handoff environments with low complexity, highly flexible equalization. The wireless communication signal may be a CIBS-CDMA signal in which a symbol block is divided into sub-blocks and spread by a user-specific block-spreading matrix. The CIBS signal is received through M subchannels and a de-spreading matrix is applied to produce a multi-user interference (MUI) free sub-block output for the mth channel. One-step block equalization comprises forming a single block from the m de-spread sub-blocks and performing block equalization on the single block. |
| FILED | Friday, May 07, 2004 |
| APPL NO | 10/841806 |
| ART UNIT | 2617 — Optics |
| CURRENT CPC | Multiplex communications 370/335 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403577 | Kumar |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Aerospace Corporation (El Segundo, California) |
| INVENTOR(S) | Rajendra Kumar (Cerritos, California) |
| ABSTRACT | A computation efficient polyphase channelization system enables one of many user FDMA signals to be channelized through multiple FFT response frequency bands forming an aggregate frequency band where K-point FFT channels are greater than the decimation factor M to produce FFT overlapped responses that have a smooth aggregate response without disjointed band gaps for reduced distortion using a clockwise commutator having M channels feeding M filter blocks, each of which having β polyphase filters, and having a ring switch to provide smooth filter responses that then drive β K-point FFTs to provide a β set of K vector FFT responses that are then combined in a post processing system for producing K channelized outputs. |
| FILED | Wednesday, June 09, 2004 |
| APPL NO | 10/864201 |
| ART UNIT | 2611 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory |
| CURRENT CPC | Pulse or digital communications 375/324 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403686 | Zervas |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Harry Zervas (Lincoln, Rhode Island) |
| ABSTRACT | The invention is a staggered splice and method for making the same. The staggered splice is used to join two multi-fiber optic cables. Each opposing pair of optic fibers is cleaved such that they all have substantially the same combined length and provide fully operable communication. The light transmitting interfaces are staggered with respect to each other. The individual splices can be mechanical or fusion splices. The splices are typically bundled and protected with a sheath. The staggered splice is particularly applicable for connecting torpedo payout spools wound with the multi-fiber optic micro cable to the shipboard side wire. |
| FILED | Thursday, November 30, 2006 |
| APPL NO | 11/645268 |
| ART UNIT | 2883 — Optics |
| CURRENT CPC | Optical waveguides 385/100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403689 | Koch, III et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Corning Incorporated (Corning, New York) |
| INVENTOR(S) | Karl W. Koch, III (Elmira, New York); James A. West (Painted Post, New York) |
| ABSTRACT | A plurality of active gain material (93) is disposed in an active interface portion (44) of a dielectric band-gap cladding confinement region (22) adjacent to a dielectric core (12) of a photonic band-gap crystal fiber (20), wherein during operation, the plurality of active gain material (93) absorbs the pump energy and stores the pump energy as a potential energy storage for stimulation by EM energy in a second guided mode at a second frequency in a second range of frequencies for overlapping with the first guided mode of the core (12) such that the surface defined by an interface between the photonic band-gap cladding (22) and the dielectric core (12) that supports at least one surface mode propagating at that interface (44) overlaps the active interface portion of the dielectric cladding confinement region and a state associated with the dielectric core (12). |
| FILED | Wednesday, November 19, 2003 |
| APPL NO | 10/716892 |
| ART UNIT | 2874 — Optics |
| CURRENT CPC | Optical waveguides 385/125 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403711 | Chen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Lucent Technologies Inc. (Murray Hill, New Jersey) |
| INVENTOR(S) | Young-Kai Chen (Berkeley Heights, New Jersey); Andreas Leven (Gillette, New Jersey) |
| ABSTRACT | An optical digital-to-analog (D/A) converter and a method of optically converting digital data into analog form. In one embodiment, the optical D/A converter includes: (1) a splitter configured to receive and split an input coherent optical carrier into a plurality of mutually coherent optical carriers, (2) a switching stage coupled to the splitter and including a corresponding plurality of selector switches configured to pass or interrupt selected ones of the plurality of coherent optical carriers responsive to pattern bits, (3) an amplitude and phase offset stage coupled to the switching stage and including a corresponding plurality of amplitude and phase offset units configured to offset amplitudes or phases of passed ones of the plurality of mutually coherent optical carriers responsive to offset signals and (4) a combiner coupled to the amplitude and phase offset stage and configured to recombine the mutually coherent optical carriers to yield an optical output signal. |
| FILED | Tuesday, November 22, 2005 |
| APPL NO | 11/284865 |
| ART UNIT | 2613 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory |
| CURRENT CPC | Optical communications 398/45 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403780 | VanLaningham et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Rockwell Collins, Inc. (Cedar Rapids, Iowa) |
| INVENTOR(S) | Steven L. VanLaningham (Richardson, Texas); Jeffrey A. Barton (Richardson, Texas); James A. Stevens (Allen, Texas); Hersh B. Parekh (Plano, Texas); C. David Young (Plano, Texas) |
| ABSTRACT | A method of adapting a communication link in a network of radio communication nodes is disclosed, The method includes sending by a first node a first radio communication, The method also includes receiving by a second node the first radio communication, Further, the method includes estimating by the second node the dynamics of the communications channel, Further still, the method includes categorizing the dynamics of the communications channel into one of at least two groups, based on the estimate, Yet further still the method includes selecting, based on the chosen group, the use of either closed loop link adaption or open loop adaption of communication link parameters. |
| FILED | Thursday, February 19, 2004 |
| APPL NO | 10/782716 |
| ART UNIT | 2618 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory |
| CURRENT CPC | Telecommunications 455/452.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403980 | Stringer-Calvert et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | SRI International (Menlo Park, California) |
| INVENTOR(S) | David W. J. Stringer-Calvert (Sunnyvale, California); Steven Mark Dawson (Menlo Park, California); Patrick D. Lincoln (Woodside, California) |
| ABSTRACT | A groupware management system for collaborative groups is disclosed that is scalable to support large, dynamic, multiple, and other virtual VPNs. The system may introduce a graph (or hierarchical) structure to the VPN, providing multiple master nodes controlling membership in subsets of the collaborative group. Use of multiple master nodes in a graph-structured (or hierarchical) network topology often relaxes the need for a single, centralized, globally consistent view of VPN group membership, and enables distribution of the management burden among multiple master nodes. Membership in the VPN may be changed dynamically by the second master node for the member nodes of the second subset, without requiring the first master node to dynamically update its group membership records to reflect the change and in many cases without even having to notify the first master node (and vice versa), for example. In further embodiments, the use of multiple master nodes may increase the reliability and efficiency of VPNs, such as by enabling load balancing of master node tasks. Fail-over mechanisms may also be used to transparently re-route management tasks to an alternate master node especially in the case of failure of the current master node serving a given member node. |
| FILED | Thursday, April 26, 2001 |
| APPL NO | 09/844693 |
| ART UNIT | 2181 — Computer Architecture and I/O |
| CURRENT CPC | Electrical computers and digital processing systems: Multicomputer data transferring 79/220 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07404074 | Murotake |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | SCA Technica, Inc. (Nashua, New Hampshire) |
| INVENTOR(S) | David K Murotake (Nashua, New Hampshire) |
| ABSTRACT | The invention in the simplest form is a self-booting software defined radio (SDR) module which may be embodied as a PCMCIA, Compact Flash, or other plug in form factor module. The performance characteristics of the module, may include the radio frequency (RF) carrier frequency, instantaneous RF bandwidth, carrier modulation and demodulation, symbol coding and decoding, security, and network protocol that can be altered and saved by means of computer software transferred to the module from a host device such as a cellular telephone, personal digital assistant, lap top computer or other programming device. |
| FILED | Monday, July 14, 2003 |
| APPL NO | 10/618950 |
| ART UNIT | 2116 — Computer Error Control, Reliability, & Control Systems |
| CURRENT CPC | Electrical computers and digital processing systems: Support 713/100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07404147 | Bell et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Trustees of Columbia University in the city of New York (New York, New York) |
| INVENTOR(S) | Blaine A Bell (New York, New York); Steven A. Feiner (New York, New York) |
| ABSTRACT | A method for space management of a workspace provided on a display includes defining a first data structure of full-space rectangles present on the workspace, wherein at least a portion of the full-space rectangles are permitted to overlap. A second data structure of largest empty-space rectangles available on the workspace is also defined to complete the representation of the workspace. The methods include performing an operation on at least one full-space rectangle on the workspace and redefining the first data structure and the second data structure in accordance with the workspace resulting from the operation performed. The operations can include adding a new full-space rectangle, moving an existing full-space rectangle and deleting an existing full full-space rectangle from the workspace. Generally, the workspace is a display device coupled to an electronic device such as a personal computer, personal digital assistant, electronic book viewer and the like. |
| FILED | Tuesday, April 24, 2001 |
| APPL NO | 10/258510 |
| ART UNIT | 2173 — Graphical User Interface and Document Processing |
| CURRENT CPC | Data processing: Presentation processing of document, operator interface processing, and screen saver display processing 715/765 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07404170 | Schott et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Southern California (Los Angeles, California) |
| INVENTOR(S) | Brian Schott (Gambrills, Maryland); Robert Parker (Oakton, Virginia) |
| ABSTRACT | An API (Application Programming Interface) for an adaptive computing system (ACS) may be used to create a system for performing an application on different types of ACS platforms. The API may be used to generate a system object including a host and a number of nodes and channels. A system data structure is created which describes the nodes, which may be FPGA (Field Programmable Gate Array)-based ACS accelerator boards. The API may enable source-code porting and scaling from small research platforms to larger field-deployable platforms. |
| FILED | Tuesday, July 05, 2005 |
| APPL NO | 11/175993 |
| ART UNIT | 2825 — Semiconductors/Memory |
| CURRENT CPC | Computer-aided design and analysis of circuits and semiconductor masks 716/16 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07404172 | Wong et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | California Institute of Technology (Pasadena, California) |
| INVENTOR(S) | Catherine G. Wong (Pasadena, California); Mika Nystroem (Pasadena, California); Alain J. Martin (Pasadena, California) |
| ABSTRACT | The present invention is a systematic and data-driven-decomposition (DDD) method and apparatus for use in VLSI synthesis. The invention decomposes a high level program circuit description into a collection of small and highly concurrent modules that can be implemented directly into transistor networks. This enables an automatic implementation of a decomposition process currently done by hand. Unlike prior art syntax-based decompositions, the method of the present invention examines data dependencies in the process' computation, and then attempts to eliminate unnecessary synchronization in the system. In one embodiment, the method comprises: a conversion to convert the input program into an intermediate Dynamic Single Assignment (DSA) form, a projection process to decompose the intermediate DSA into smaller concurrent processes, and a clustering process that optimally groups small concurrent processes to make up the final decomposition. Another embodiment is a decomposition, projection, and clustering tool implemented in computer program codes. |
| FILED | Friday, December 19, 2003 |
| APPL NO | 10/741839 |
| ART UNIT | 2825 — Semiconductors/Memory |
| CURRENT CPC | Computer-aided design and analysis of circuits and semiconductor masks 716/18 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Health and Human Services (HHS)
| US 07401519 | Kardous |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia) |
| INVENTOR(S) | Chucri A. Kardous (Florence, Kentucky) |
| ABSTRACT | In one embodiment, a system for monitoring exposure to impulse noise includes a sound-sensing device, such as a microphone or other type of pressure transducer, operable to sense impulse noise, and a storage module operable to store the waveform of the impulse noise sensed by the sound-sensing device. The sound-sensing device desirably is operable to sense impulses that are greater than 146 dB, such as impulses created by construction machinery and firearms. The system also can include a processor operable to calculate one or more noise parameters of the impulse noise from the waveform, and a user interface program operable to display said one or more noise parameters selected by a user. |
| FILED | Tuesday, July 13, 2004 |
| APPL NO | 10/564860 |
| ART UNIT | 2856 — Printing/Measuring and Testing |
| CURRENT CPC | Measuring and testing 073/646 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402153 | Steil et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Medtronic MiniMed, Inc. (Northridge, California) |
| INVENTOR(S) | Garry M. Steil (Pasadena, California); Kerstin Rebrin (Alameda, California) |
| ABSTRACT | A closed loop infusion system controls the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The sensor signal is used to generate a controller input. The controller uses the controller input to generate commands to operate the delivery system. The delivery system infuses a liquid into the user at a rate dictated by the commands from the controller. Preferably, the sensor system monitors the glucose concentration in the body of the user, and the liquid infused by the delivery system into the body of the user includes insulin. |
| FILED | Wednesday, March 31, 2004 |
| APPL NO | 10/816021 |
| ART UNIT | 3767 — Business Methods - Incentive Programs, Coupons; Electronic Shopping; Business Cryptography, Voting; Health Care; Point of Sale, Inventory, Accounting; Business Processing, Electronic Negotiation |
| CURRENT CPC | Surgery 64/131 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402298 | Kinch et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Purdue Research Foundation (West LaFayette, Indiana); SmithKline Beecham Corporation (Philadelphia, Pennsylvania) |
| INVENTOR(S) | Michael Scott Kinch (Laytonsville, Maryland); Kelly Carles-Kinch (Laytonsville, Maryland); Katherine E Kilpatrick (Durham, North Carolina) |
| ABSTRACT | The invention provides a monoclonal antibody, a fragment thereof, or a molecular complex thereof that binds to an extracellular domain of an EphA2 receptor molecule, wherein binding of the monoclonal antibody or fragment thereof to the EphA2 receptor molecule present in the membrane of a cancer cell favorably alters activity of the EphA2 receptor molecule. The invention further relates to methods of making and using the monoclonal antibodies, fragments, and molecular complexes regarding the same. The monoclonal antibodies of the present invention target the extracellular domain of EphA2 and operate to redirect the function of EphA2 to selectively block the growth and invasiveness of metastatic cells. The invention thus makes possible therapeutic strategies that optimally target metastatic cells while preventing collateral damage to normal tissues. |
| FILED | Thursday, December 02, 2004 |
| APPL NO | 11/004005 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/9.340 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402306 | Cohen |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Board of Trustees of the University of Illinois (Urbana, Illinois) |
| INVENTOR(S) | Edward P. Cohen (Chicago, Illinois) |
| ABSTRACT | The present invention relates to improved semi-allogeneic immunogenic cells which act to stimulate and induce an immunological response when administered to an individual. In particular, it relates to cells which express both allogeneic and syngeneic MHC determinants and which also express at least one antigen recognized by T lymphocytes. The invention is also directed to methods of inducing an immune response and methods of treating tumors by administering the semi-allogeneic immunogenic cells to an individual. |
| FILED | Friday, March 10, 2000 |
| APPL NO | 09/522716 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/93.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402314 | Sherman |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Scripps Research Institute (La Jolla, California) |
| INVENTOR(S) | Linda A. Sherman (La Jolla, California) |
| ABSTRACT | The present invention relates to methods and compositions of activating cytotoxic T lymphocytes (CTLs) in vivo with specificity for particular antigenic peptides, and to methods and compositions of using activated CTLs in vivo for the treatment of a variety of disease conditions. In some preferred embodiments, the invention provides methods of employing a polypeptide of the amino acid sequence VMAGVGSPYV to specifically activating CTLs in subjects having a breast cancer overexpressing a Her-2/Neu protein, and methods of using the polypeptide to treat such subjects. |
| FILED | Friday, March 26, 1999 |
| APPL NO | 09/277064 |
| ART UNIT | 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/184.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402316 | Dale |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Tennessee Research Foundation (Knoxville, Tennessee) |
| INVENTOR(S) | James B Dale (Memphis, Tennessee) |
| ABSTRACT | The present invention provides methods for eliciting an immune response against Group A streptococci, comprising use of recombinant fusion polypeptides, and compositions thereof, that include a multivalent immunogenic portion of at least two immunogenic polypeptides from Group A streptococci M proteins (which are capable of stimulating a protective immune response against Group A streptococci), and a reiterated polypeptide from the immunogenic portion carboxy-terminal to the immunogenic portion, wherein the carboxy-terminal polypeptide is not required to stimulate an immune response against Group A streptococci. |
| FILED | Tuesday, February 17, 2004 |
| APPL NO | 10/780106 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/244.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402319 | Schmidt et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Board of Regents, The University of Texas System (Austin, Texas) |
| INVENTOR(S) | Christine Schmidt (Austin, Texas); Terry Hudson (Barboursville, Virginia) |
| ABSTRACT | The present invention is a natural, cell-free tissue replacement that does not require difficult or extensive preparation made by washing tissue replacement in a solution including one or more sulfobetaines and an anionic surface-active detergent and washing the tissue replacement in serial solutions of the buffered salt to remove excess detergent. The natural, cell-free tissue replacement may be a nerve graft that supports axonal regeneration, guides the axons toward the distal nerve end and/or is immunologically tolerated. Other forms of the invention are a composition and kit prepared by the method of making a native, cell-free tissue replacement. The present invention may be modified for use in diagnostic, therapeutic, and prophylactic applications. |
| FILED | Friday, September 26, 2003 |
| APPL NO | 10/672689 |
| ART UNIT | 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/422 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402385 | Dadachova et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Albert Einstein College of Medicine of Yeshiva University (Bronx, New York) |
| INVENTOR(S) | Ekaterina Dadachova (Mahopac, New York); Joshua D. Nosanchuk (Upper Saddle River, New Jersey); Arturo Casadevall (Pelham, New York) |
| ABSTRACT | This invention provides methods for imaging and/or treating a tumor in a subject which comprise administering to the subject an amount of a radiolabeled antibody effective to image and/or treat the tumor, where the radiolabeled antibody binds to a cellular component released by dying tumor cells. This invention also provides methods for imaging and/or treating melanin-containing melanomas in a subject which comprise administering to the subject an amount of a radiolabeled anti-melanin antibody effective to image and/or treat the melanoma. The invention also provides compositions and methods of making compositions comprising radiolabeled antibodies for imaging and treating tumors, including melanin-containing melanomas. |
| FILED | Tuesday, February 10, 2004 |
| APPL NO | 10/775869 |
| ART UNIT | 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
07402387 — Methods and compositions for detecting dihydropyrimidine dehydrogenase splicing mutations
| US 07402387 | Gonzalez et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Department of Health and Human Services (Washington, District of Columbia) |
| INVENTOR(S) | Frank J. Gonzalez (Bethesda, Maryland); Pedro Fernandez-Salguero (Bethesda, Maryland) |
| ABSTRACT | The present invention provides compositions, methods, and kits for the detection of genetic polymorphisms or mutations of the dihydropyrimidine dehydrogenase deficiency (DPDD). The polymorphisms or mutations generally occur in the dihydropyrimidine dehydrogenase (DPD) gene in chromosome 1. Also provided are mutant forms of DPD. |
| FILED | Tuesday, August 03, 2004 |
| APPL NO | 10/911237 |
| ART UNIT | 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/6 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402392 | Hallahan et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Vanderbilt University (Nashville, Tennessee) |
| INVENTOR(S) | Dennis E. Hallahan (Nashville, Tennessee); Shimian Qu (Brentwood, Tennessee) |
| ABSTRACT | A method for identifying a molecule that binds an irradiated tumor in a subject and molecules identified thereby. The method includes the steps of: (a) exposing a tumor to ionizing radiation; (b) administering to a subject a library of diverse molecules; and (c) isolating from the tumor one or more molecules of the library of diverse molecules, whereby a molecule that binds an irradiated tumor is identified. Also provided are therapeutic and diagnostic methods using targeting ligands that bind an irradiated tumor. |
| FILED | Friday, September 27, 2002 |
| APPL NO | 10/259087 |
| ART UNIT | 1639 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/7.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402400 | Zuker et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Regents of the University of California (Oakland, California); The United States of America Department of Health and Human Services (Washington, District of Columbia) |
| INVENTOR(S) | Charles S. Zuker (San Diego, California); Nicholas J. P. Ryba (Bethesda, Maryland); Gregory A. Nelson (San Diego, California); Mark A. Hoon (Kensington, Maryland); Jayaram Chandrashekar (San Diego, California); Yifeng Zhang (La Jolla, California) |
| ABSTRACT | The present invention provides isolated nucleic acid and amino acid sequences of sweet taste receptors comprising two heterologous G-protein coupled receptor polypeptides from the T1R family of sensory G-protein coupled receptors, antibodies to such receptors, methods of detecting such nucleic acids and receptors, and methods of screening for modulators of sweet taste receptors. |
| FILED | Friday, August 10, 2001 |
| APPL NO | 09/927315 |
| ART UNIT | 1649 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/7.210 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402402 | Osborne et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Baylor College of Medicine (Houston, Texas) |
| INVENTOR(S) | C. Kent Osborne (Houston, Texas); Rachel Schiff (Bellaire, Texas); Jiang Shou (Houston, Texas) |
| ABSTRACT | Acquired and de novo endocrine resistance are major clinical problems in the management of breast cancer patients. Though the antiestrogen tamoxifen prolongs disease-free and overall survival in the adjuvant setting, and induces remissions in over half of the patients with estrogen receptor positive metastatic disease, all patients eventually acquire tamoxifen resistance. Furthermore, many of the resistant tumors actually appear to be stimulated by tamoxifen just as they are by estrogens. The present invention provides methods of predicting endocrine resistance comprising detecting the biological activity and/or expression of p38 MAPK and/or AIB1. The invention further provides methods of reducing, reversing, or preventing endocrine resistance comprising contacting a breast or prostate tumor with a p38 MAPK pathway inhibitor. |
| FILED | Sunday, April 29, 2007 |
| APPL NO | 11/741762 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/7.230 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402417 | Croteau et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Washington State University Research Foundation (Pullman, Washington) |
| INVENTOR(S) | Rodney B. Croteau (Pullman, Washington); Robert Long (Moscow, Idaho); Stefan Jennewein (Alfdorf, Germany) |
| ABSTRACT | This disclosure provides the nucleic acid and protein sequences of novel P450 oxygenases that utilize, at least, taxoid substrates, including taxadiene isomers. The disclosed oxygenases, such as a taxoid 5α-hydroxylase, hydroxylate, at least, the C5 position of a taxoid. Also provided are methods of introducing oxygen at the C5 position of a taxoid and methods of producing the anti-cancer drug, paclitaxel (also known as Taxol™), and other taxoids, such as paclitaxel intermediates. |
| FILED | Wednesday, July 21, 2004 |
| APPL NO | 10/565233 |
| ART UNIT | 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/189 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402432 | Clark et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Brigham and Women's Hospital, Inc. (Boston, Massachusetts) |
| INVENTOR(S) | Rachael A. Clark (Belmont, Massachusetts); Thomas Kupper (Weston, Massachusetts) |
| ABSTRACT | The present invention is directed to an in vitro method for producing T lymphocytes. The method involves culturing bone marrow cells on a matrix seeded with keratinocytes and fibroblasts. |
| FILED | Tuesday, December 07, 2004 |
| APPL NO | 11/005481 |
| ART UNIT | 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/373 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402434 | Newman et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | |
| INVENTOR(S) | Stuart A. Newman (Pleasantville, New York); Natalie B. Bronstein (Patterson, New York) |
| ABSTRACT | The invention relates to methods and reagents for influencing alternative RNA splicing in living cells. More particularly, the invention relates to novel means for influencing RNA splice choice in living cells using polynucleotide-based reagents that compete for binding sites in nucleotide binding proteins, and novel methods for using these reagents as therapeutics. |
| FILED | Tuesday, May 08, 2001 |
| APPL NO | 09/849967 |
| ART UNIT | 1642 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/455 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402567 | Chojkier et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California); The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) (Washington, District of Columbia) |
| INVENTOR(S) | Mario Chojkier (San Diego, California); Martina Buck (San Diego, California) |
| ABSTRACT | The present invention relates generally to the treatment and prevention of diseases characterized by excess cell proliferation and/or activation. In particular, the present invention provides compositions and methods to suppress the activation and/or proliferation of various cells. In preferred embodiments, the present invention provides compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells (including, but not limited to hepatic stellate cells), as well as cells with abnormal growth characteristics. In particularly preferred embodiments, the present invention provides compositions and methods to induce fibrosis. |
| FILED | Friday, October 26, 2001 |
| APPL NO | 10/415325 |
| ART UNIT | 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/18 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402570 | Kinzler et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Johns Hopkins University (Baltimore, Maryland) |
| INVENTOR(S) | Kenneth W. Kinzler (Baltimore, Maryland); Bert Vogelstein (Baltimore, Maryland) |
| ABSTRACT | A human gene has been discovered which is genetically altered in human tumor cells. The genetic alteration is gene amplification and leads to a corresponding increase in gene products. Detecting that the gene, designated hMDM2, has become amplified or detecting increased expression of gene products is diagnostic of tumorigenesis. Human MDM2 protein binds to human p53 and allows the cell to escape from p53-regulated growth. |
| FILED | Monday, October 01, 2001 |
| APPL NO | 09/966724 |
| ART UNIT | 1635 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/44 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402572 | Krieg et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Iowa Research Foundation (Iowa City, Iowa) |
| INVENTOR(S) | Arthur M. Krieg (Wellesley, Massachusetts); Joel N. Kline (Iowa City, Iowa) |
| ABSTRACT | Nucleic acids containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response and to redirect a Th2 response to a Th1 response in a subject are disclosed. Methods for treating atopic diseases, including atopic dermatitis, are disclosed. |
| FILED | Friday, April 23, 2004 |
| APPL NO | 10/831647 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/44 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402588 | Liotta et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Emory University (Atlanta, Georgia) |
| INVENTOR(S) | Dennis C. Liotta (Stone Mountain, Georgia); Raymond F. Schinazi (Decatur, Georgia); Woo-Baeg Choi (North Brunswick, New Jersey) |
| ABSTRACT | A method and composition for the treatment of HIV and HBV infections in humans is disclosed that includes administering an effective amount of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane, a pharmaceutically acceptable derivative thereof, including a 5′ or N4 alkylated or acylated derivative, or a pharmaceutically acceptable salt thereof, in a pharmaceutically acceptable carrier. A process for the resolution of a racemic mixture of nucleoside enantiomers is also disclosed that includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers. |
| FILED | Tuesday, March 28, 2006 |
| APPL NO | 11/390861 |
| ART UNIT | 1624 — Organic Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/274 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402660 | St. Croix et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Johns Hopkins University (Baltimore, Maryland) |
| INVENTOR(S) | Brad St. Croix (Cockeysville, Maryland); Bert Vogelstein (Baltimore, Maryland); Kenneth W. Kinzler (BelAir, Maryland) |
| ABSTRACT | To gain a better understanding of tumor angiogenesis, new techniques for isolating endothelial cells (ECs) and evaluating gene expression patterns were developed. When transcripts from ECs derived from normal and malignant colorectal tissues were compared with transcripts from non-endothelial cells, over 170 genes predominantly expressed in the endothelium were identified. Comparison between normal- and tumor-derived endothelium revealed 79 differentially expressed genes, including 46 that were specifically elevated in tumor-associated endothelium. Experiments with representative genes from this group demonstrated that most were similarly expressed in the endothelium of primary lung, breast, brain, and pancreatic cancers as well as in metastatic lesions of the liver. These results demonstrate that neoplastic and normal endothelium in humans are distinct at the molecular level, and have significant implications for the development of anti-angiogenic therapies in the future. |
| FILED | Wednesday, August 01, 2001 |
| APPL NO | 09/918715 |
| ART UNIT | 1643 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/387.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402665 | Spradling et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Carnegie Institution of Washington (Washington, District of Columbia) |
| INVENTOR(S) | Allan C. Spradling (Baltimore, Maryland); Dianne Stewart Williams (Baltimore, Maryland); Alexei V. Tulin (Baltimore, Maryland) |
| ABSTRACT | Poly(ADP)-ribose polymerase (PARP) becomes activated at sites of DNA damage and is thought to promote repair by modifying local chromatin proteins and transcription factors. Disclosed is an isoform of PARP, PARP-e, which lacks enzymatic function and which is encoded by a gene having a novel structure. Also disclosed are methods of modulating chromatin structure resulting in modulation of gene activation, gene repression and chromatin condensation and decondensation. |
| FILED | Thursday, July 31, 2003 |
| APPL NO | 10/630660 |
| ART UNIT | 1652 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Organic compounds 536/23.400 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402725 | Ramesh et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Children's Medical Center Corporation (Boston, Massachusetts) |
| INVENTOR(S) | Narayanaswamy Ramesh (Wayland, Massachusetts); Miguel A. de la Fuente (Boston, Massachusetts); Ines M. Anton (Turin, Italy); Raif S. Geha (Belmont, Massachusetts) |
| ABSTRACT | Described herein is a novel gene and its product, WIP, which associates with WASP. The subject invention relates to the isolated WIP gene or cDNA and transgenic mammals that have the WIP gene disrupted in their genome. Also the subject of this invention are methods of treating conditions or diseases in which WIP and/or WASP DNA or protein is deficient and/or defective, for example, mutated or altered, such that an individual is adversely affected. Also described are methods of altering or regulating WIP and its functions in a mammal or in a cell of a mammal, for example in a lymphocyte. A further subject of this invention is an assay to identify drugs which alter the activity of WIP or expression of WIP DNA. |
| FILED | Friday, May 20, 2005 |
| APPL NO | 11/134068 |
| ART UNIT | 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Multicellular living organisms and unmodified parts thereof and related processes 8/3 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402726 | Pallanck et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The University of Washington (Seattle, Washington) |
| INVENTOR(S) | Leo J. Pallanck (Seattle, Washington); Jessica G. Zuniga (Redmond, Washington); Alexander J. Whitworth (Seattle, Washington) |
| ABSTRACT | Methods and compositions for identifying an agent (e.g., a gene product or small molecule compound) that modulates a Parkinson's disease phenotype are provided. In practicing the subject methods, a non-mammalian animal model, such as Drosophila melanogaster, that includes a mutant parkin gene and at least one other mutant gene are evaluated for a Parkinson's disease phenotype. Also provided are kits, and systems for practicing the subject methods, as well as methods of use of agents identified in the screening method of the invention. |
| FILED | Tuesday, February 08, 2005 |
| APPL NO | 11/054358 |
| ART UNIT | 1632 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Multicellular living organisms and unmodified parts thereof and related processes 8/8 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402777 | Ron et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Alexza Pharmaceuticals, Inc. (Palo Alto, California) |
| INVENTOR(S) | Hale L. Ron (Woodside, California); Mingzu Lei (Mountain View, California); Hilary N. Pettit (Newark, California); Dennis W. Solas (San Francisco, California); Soonho Song (Palo Alto, California); Curtis Tom (San Mateo, California) |
| ABSTRACT | High sparking initiator compositions with a controlled amount of power are disclosed. The initiator compositions comprise a metal containing oxidizing agent, at least one metal reducing agent, and a non-explosive binder. Low voltage igniters that provide bidirectional plumes upon ignition are also disclosed. These igniters have a electrically resistive element positioned across a hole in a support which directs the plume. These igniters and compositions are useful in the actuation of solid fuel heating unit, in particular, sealed heating units. |
| FILED | Thursday, May 20, 2004 |
| APPL NO | 10/851018 |
| ART UNIT | 3742 — Electrical Circuits and Systems |
| CURRENT CPC | Electric heating 219/270 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403006 | Garwood et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Regents of the University of Minnesota (Minneapolis, Minnesota) |
| INVENTOR(S) | Michael Garwood (Medina, Minnesota); Djaudat S. Idiyatullin (Minneapolis, Minnesota) |
| ABSTRACT | A method of magnetic resonance is provided that uses a frequency swept excitation wherein the acquired signal is a time domain signal is provided. In one embodiment, the sweeping frequency excitation has a duration and is configured to sequentially excite isochromats having different resonant frequencies. Acquisition of the time domain signal is done during the duration of the sweeping frequency excitation. The time domain signal is based on evolution of the isochromats. |
| FILED | Wednesday, October 11, 2006 |
| APPL NO | 11/548664 |
| ART UNIT | 2831 — Electrical Circuits and Systems |
| CURRENT CPC | Electricity: Measuring and testing 324/310 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403281 | Carron et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Wyoming (Laramie, Wyoming); Delta Nu a division of CC Technology, Inc. (Laramie, Wyoming) |
| INVENTOR(S) | Keith T. Carron (Centennial, Wyoming); Mark A. Watson (Laramie, Wyoming); Shane A. Buller (Laramie, Wyoming) |
| ABSTRACT | A system, method and apparatus for taking a Raman spectrum of a sample is disclosed. In one embodiment, for example, an integrated Raman spectrometer is provided. In another embodiment, a portable Raman spectrometer is provided. In another embodiment, a Raman spectrometer is provided comprising a collimated beam tube for transmitting excitation radiation to an external optical system, such as a microscope, a telescope or a camera lens. In another embodiment, a method for correcting a Raman spectrum for background interference is provided. In yet another embodiment, a method for rejecting fluorescence in a Raman spectrometer is provided. A chemical reactor comprising a built-in Raman detector for monitoring a chemical reaction in a reaction chamber of the reactor is also provided. |
| FILED | Tuesday, June 01, 2004 |
| APPL NO | 10/859372 |
| ART UNIT | 2886 — Optics |
| CURRENT CPC | Optics: Measuring and testing 356/301 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403810 | Li et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Northwestern University (Evanston, Illinois) |
| INVENTOR(S) | Debiao Li (Naperville, Illinois); Jordin D. Green (Chicago, Illinois) |
| ABSTRACT | In a method and apparatus for contrast-enhanced magnetic resonance (MR) angiography of the right coronary artery of a patient, a bolus of MR contrast agent is selected to have a size that will cause the bolus, after injection into the patient, to wash out of right coronary chambers of the heart while still enhancing MR signals from the right coronary artery. The bolus of MR contrast agent is injected into the patient, and MR signals are generated in, and MR signals are obtained from, the patient in a time window after the bolus has washed out of the right coronary chambers and still enhances MR signals in the right coronary artery. An MR image of the right coronary artery is generated using only the MR signals obtained in the time window. |
| FILED | Wednesday, May 19, 2004 |
| APPL NO | 10/848950 |
| ART UNIT | 3737 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory |
| CURRENT CPC | Surgery 6/419 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07404147 | Bell et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Trustees of Columbia University in the city of New York (New York, New York) |
| INVENTOR(S) | Blaine A Bell (New York, New York); Steven A. Feiner (New York, New York) |
| ABSTRACT | A method for space management of a workspace provided on a display includes defining a first data structure of full-space rectangles present on the workspace, wherein at least a portion of the full-space rectangles are permitted to overlap. A second data structure of largest empty-space rectangles available on the workspace is also defined to complete the representation of the workspace. The methods include performing an operation on at least one full-space rectangle on the workspace and redefining the first data structure and the second data structure in accordance with the workspace resulting from the operation performed. The operations can include adding a new full-space rectangle, moving an existing full-space rectangle and deleting an existing full full-space rectangle from the workspace. Generally, the workspace is a display device coupled to an electronic device such as a personal computer, personal digital assistant, electronic book viewer and the like. |
| FILED | Tuesday, April 24, 2001 |
| APPL NO | 10/258510 |
| ART UNIT | 2173 — Graphical User Interface and Document Processing |
| CURRENT CPC | Data processing: Presentation processing of document, operator interface processing, and screen saver display processing 715/765 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Energy (DOE)
| US 07402234 | Lessing |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Battelle Energy Alliance, LLC (Idaho Falls, Idaho) |
| INVENTOR(S) | Paul A. Lessing (Idaho Falls, Idaho) |
| ABSTRACT | An electrochemically active hydrogen diffusion barrier which comprises an anode layer, a cathode layer, and an intermediate electrolyte layer, which is conductive to protons and substantially impermeable to hydrogen. A catalytic metal present in or adjacent to the anode layer catalyzes an electrochemical reaction that converts any hydrogen that diffuses through the electrolyte layer to protons and electrons. The protons and electrons are transported to the cathode layer and reacted to form hydrogen. The hydrogen diffusion barrier is applied to a polymeric substrate used in a storage tank to store hydrogen under high pressure. A storage tank equipped with the electrochemically active hydrogen diffusion barrier, a method of fabricating the storage tank, and a method of preventing hydrogen from diffusing out of a storage tank are also disclosed. |
| FILED | Tuesday, June 29, 2004 |
| APPL NO | 10/881871 |
| ART UNIT | 1795 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Electrolysis: Processes, compositions used therein, and methods of preparing the compositions 25/763 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402448 | Narayanan et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | BP Corporation North America Inc. (Warrenville, Illinois) |
| INVENTOR(S) | Srinivasamohan Narayanan (Gaithersburg, Maryland); Bikash Kumar (Bangalore, India) |
| ABSTRACT | An efficient photovoltaic cell, and its process of manufacture, is disclosed wherein the back surface p-n junction is removed from a doped substrate having an oppositely doped emitter layer. A front surface and edges and optionally the back surface periphery are masked and a back surface etch is performed. The mask is not removed and acts as an anti-reflective coating, a passivating agent, or both. The photovoltaic cell retains an untextured back surface whether or not the front is textured and the dopant layer on the back surface is removed to enhance the cell efficiency. Optionally, a back surface field is formed. |
| FILED | Wednesday, January 28, 2004 |
| APPL NO | 10/767625 |
| ART UNIT | 2891 — Semiconductors/Memory |
| CURRENT CPC | Semiconductor device manufacturing: Process 438/48 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402542 | Wagh et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | UChicago Argonne, LLC (Chicago, Illinois) |
| INVENTOR(S) | Arun S. Wagh (Orland Park, Illinois); Allison L. Antink (Bolingbrook, Illinois) |
| ABSTRACT | A structural material of a polystyrene base and the reaction product of the polystyrene base and a solid phosphate ceramic is applied as a slurry which includes one or more of a metal oxide or a metal hydroxide with a source of phosphate to produce a phosphate ceramic and a poly (acrylic acid or acrylate) or combinations or salts thereof and polystyrene or MgO applied to the polystyrene base and allowed to cure so that the dried aqueous slurry chemically bonds to the polystyrene base. A method is also disclosed of applying the slurry to the polystyrene base. |
| FILED | Monday, August 15, 2005 |
| APPL NO | 11/204331 |
| ART UNIT | 1796 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Compositions: Ceramic 51/111 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403065 | Gresham et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Sandia Corporation (Albuquerque, New Mexico); Arizona Board of Regents (Tucson, Arizona) |
| INVENTOR(S) | Christopher A. Gresham (Albuquerque, New Mexico); M. Bonner Denton (Tucson, Arizona); Roger P. Sperline (Tucson, Arizona) |
| ABSTRACT | A differential transimpedance amplifier circuit for correlated differential amplification. The amplifier circuit increase electronic signal-to-noise ratios in charge detection circuits designed for the detection of very small quantities of electrical charge and/or very weak electromagnetic waves. A differential, integrating capacitive transimpedance amplifier integrated circuit comprising capacitor feedback loops performs time-correlated subtraction of noise. |
| FILED | Tuesday, August 22, 2006 |
| APPL NO | 11/507838 |
| ART UNIT | 2817 — Semiconductors/Memory |
| CURRENT CPC | Amplifiers 330/9 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403585 | Ougouag et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Battelle Energy Alliance, LLC (Idaho Falls, Idaho) |
| INVENTOR(S) | Abderrafi M. Ougouag (Idaho Falls, Idaho); William K. Terry (Shelley, Idaho); Hans D. Gougar (Idaho Falls, Idaho) |
| ABSTRACT | An improved nuclear fission reactor of the continuous fueling type involves determining an asymptotic equilibrium state for the nuclear fission reactor and providing the reactor with a moderator-to-fuel ratio that is optimally moderated for the asymptotic equilibrium state of the nuclear fission reactor; the fuel-to-moderator ratio allowing the nuclear fission reactor to be substantially continuously operated in an optimally moderated state. |
| FILED | Thursday, July 01, 2004 |
| APPL NO | 10/884341 |
| ART UNIT | 3663 — Computerized Vehicle Controls and Navigation, Radio Wave, Optical and Acoustic Wave Communication, Robotics, and Nuclear Systems |
| CURRENT CPC | Induced nuclear reactions: Processes, systems, and elements 376/381 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403592 | Haskel et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Department of Energy (Washington, District of Columbia) |
| INVENTOR(S) | Daniel Haskel (Naperville, Illinois); Jonathan C. Lang (Naperville, Illinois); George Srajer (Oak Park, Illinois) |
| ABSTRACT | The polarization and diffraction characteristics of x-rays incident upon a magnetic material are manipulated to provide a desired magnetic sensitivity in the material. The contrast in diffracted intensity of opposite helicities of circularly polarized x-rays is measured to permit separation of magnetic signals by element type and by atomic environment. This allows for the direct probing of magnetic signals from elements of the same species in nonequivalent atomic environments to better understand the behavior and characteristics of permanent magnetic materials. By using known crystallographic information together with manipulation of the polarization of x-rays having energies tuned near element-specific electronic excitations and by detecting and comparing the incident and diffracted photons at the same frequency, more accurate magnetic measurements can be made over shorter observation periods. |
| FILED | Wednesday, May 31, 2006 |
| APPL NO | 11/447511 |
| ART UNIT | 2882 — Optics |
| CURRENT CPC | X-ray or gamma ray systems or devices 378/71 |
| VIEW PATENT | @ USPTO: Full Text PDF |
National Science Foundation (NSF)
| US 07402319 | Schmidt et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Board of Regents, The University of Texas System (Austin, Texas) |
| INVENTOR(S) | Christine Schmidt (Austin, Texas); Terry Hudson (Barboursville, Virginia) |
| ABSTRACT | The present invention is a natural, cell-free tissue replacement that does not require difficult or extensive preparation made by washing tissue replacement in a solution including one or more sulfobetaines and an anionic surface-active detergent and washing the tissue replacement in serial solutions of the buffered salt to remove excess detergent. The natural, cell-free tissue replacement may be a nerve graft that supports axonal regeneration, guides the axons toward the distal nerve end and/or is immunologically tolerated. Other forms of the invention are a composition and kit prepared by the method of making a native, cell-free tissue replacement. The present invention may be modified for use in diagnostic, therapeutic, and prophylactic applications. |
| FILED | Friday, September 26, 2003 |
| APPL NO | 10/672689 |
| ART UNIT | 1651 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/422 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402884 | Xie |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California) |
| INVENTOR(S) | Ya-Hong Xie (Beverly Hills, California) |
| ABSTRACT | An integrated circuit laminate with a metal substrate for use with high performance mixed signal integrated circuit applications. The metal substrate provides substantially improved crosstalk isolation, enhanced heat sinking and an easy access to a true low impedance ground. In one embodiment, the metal layer has regions with insulation filled channels or voids and a layer of insulator such as unoxidized porous silicon disposed between the metal substrate and a silicon integrated circuit layer. The laminate also has a plurality of metal walls or trenches mounted to the metal substrate and transacting the silicon and insulation layers thereby isolating noise sensitive elements from noise producing elements on the chip. In another embodiment, the laminate is mounted to a flexible base to limit the flexion of the chip. |
| FILED | Monday, April 10, 2006 |
| APPL NO | 11/402209 |
| ART UNIT | 2818 — Semiconductors/Memory |
| CURRENT CPC | Active solid-state devices 257/499 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403008 | Blank et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Cornell Research Foundation, Inc. (Ithaca, New York) |
| INVENTOR(S) | Aharon Blank (Ithaca, New York); Curt R. Dunnam (Trumansburg, New York); Peter P. Borbat (Ithaca, New York); Jack H. Freed (Ithaca, New York) |
| ABSTRACT | ESR microscope systems and methods for examining specimens using both continuous wave and pulsed modes in the 9 to 60 GHz range. The ESR microscope uses an image probe comprising gradient coils in addition to conventional modulation coils (in continuous wave mode) or magnetic field bias coils (in pulse mode), and a resonator constructed from high permittivity material. The systems and methods also involves the use of sample containers that permit the precise placement of samples in relation to the image probe. The microscope uses a microstrip or thin coaxial or dielectric antenna to obtain a high coupling coefficient to the specimen being imaged. The microscope systems provide resolution at the single micron level, and permit the observation of images comprising tens to hundreds of pixels for each of two or three dimensions in a few minutes. Novel stable radicals used as the imaging media are also described. |
| FILED | Tuesday, August 02, 2005 |
| APPL NO | 11/195388 |
| ART UNIT | 2831 — Electrical Circuits and Systems |
| CURRENT CPC | Electricity: Measuring and testing 324/316 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403509 | Giannakis et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Regents of the University of Minnesota (Minneapolis, Minnesota) |
| INVENTOR(S) | Georgios B. Giannakis (Minnetonka, Minnesota); Shengli Zhou (Ashford, Connecticut) |
| ABSTRACT | Techniques are described for performing block equalization on a received wireless communication signal formed according to interleaved chips generated from sub-blocks of symbols. For example, a one-step block equalization process is described which produces estimates of the information-bearing symbols from a wireless communication signal received from two or more transmitters in a soft handoff environment. The techniques provide improved performance in high load, soft handoff environments with low complexity, highly flexible equalization. The wireless communication signal may be a CIBS-CDMA signal in which a symbol block is divided into sub-blocks and spread by a user-specific block-spreading matrix. The CIBS signal is received through M subchannels and a de-spreading matrix is applied to produce a multi-user interference (MUI) free sub-block output for the mth channel. One-step block equalization comprises forming a single block from the m de-spread sub-blocks and performing block equalization on the single block. |
| FILED | Friday, May 07, 2004 |
| APPL NO | 10/841806 |
| ART UNIT | 2617 — Optics |
| CURRENT CPC | Multiplex communications 370/335 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Veterans Affairs (DVA)
| US 07402316 | Dale |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | University of Tennessee Research Foundation (Knoxville, Tennessee) |
| INVENTOR(S) | James B Dale (Memphis, Tennessee) |
| ABSTRACT | The present invention provides methods for eliciting an immune response against Group A streptococci, comprising use of recombinant fusion polypeptides, and compositions thereof, that include a multivalent immunogenic portion of at least two immunogenic polypeptides from Group A streptococci M proteins (which are capable of stimulating a protective immune response against Group A streptococci), and a reiterated polypeptide from the immunogenic portion carboxy-terminal to the immunogenic portion, wherein the carboxy-terminal polypeptide is not required to stimulate an immune response against Group A streptococci. |
| FILED | Tuesday, February 17, 2004 |
| APPL NO | 10/780106 |
| ART UNIT | 1645 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 424/244.100 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402567 | Chojkier et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Regents of the University of California (Oakland, California); The United States of America as represented by the Department of Veterans Affairs, Office of the General Counsel (024) (Washington, District of Columbia) |
| INVENTOR(S) | Mario Chojkier (San Diego, California); Martina Buck (San Diego, California) |
| ABSTRACT | The present invention relates generally to the treatment and prevention of diseases characterized by excess cell proliferation and/or activation. In particular, the present invention provides compositions and methods to suppress the activation and/or proliferation of various cells. In preferred embodiments, the present invention provides compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells (including, but not limited to hepatic stellate cells), as well as cells with abnormal growth characteristics. In particularly preferred embodiments, the present invention provides compositions and methods to induce fibrosis. |
| FILED | Friday, October 26, 2001 |
| APPL NO | 10/415325 |
| ART UNIT | 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/18 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402588 | Liotta et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Emory University (Atlanta, Georgia) |
| INVENTOR(S) | Dennis C. Liotta (Stone Mountain, Georgia); Raymond F. Schinazi (Decatur, Georgia); Woo-Baeg Choi (North Brunswick, New Jersey) |
| ABSTRACT | A method and composition for the treatment of HIV and HBV infections in humans is disclosed that includes administering an effective amount of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane, a pharmaceutically acceptable derivative thereof, including a 5′ or N4 alkylated or acylated derivative, or a pharmaceutically acceptable salt thereof, in a pharmaceutically acceptable carrier. A process for the resolution of a racemic mixture of nucleoside enantiomers is also disclosed that includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers. |
| FILED | Tuesday, March 28, 2006 |
| APPL NO | 11/390861 |
| ART UNIT | 1624 — Organic Chemistry |
| CURRENT CPC | Drug, bio-affecting and body treating compositions 514/274 |
| VIEW PATENT | @ USPTO: Full Text PDF |
National Aeronautics and Space Administration (NASA)
| US 07401397 | Shcheglov et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The Boeing Company (Chicago, Illinois); California Institute of Technology (Pasadena, California) |
| INVENTOR(S) | Kirill V. Shcheglov (Los Angeles, California); A. Dorian Challoner (Manhattan Beach, California) |
| ABSTRACT | The present invention discloses an inertial sensor comprising a planar mechanical resonator with embedded sensing and actuation for substantially in-plane vibration and having a central rigid support for the resonator. At least one excitation or torquer electrode is disposed within an interior of the resonator to excite in-plane vibration of the resonator and at least one sensing or pickoff electrode is disposed within the interior of the resonator for sensing the motion of the excited resonator. In one embodiment, the planar resonator includes a plurality of slots in an annular pattern; in another embodiment, the planar mechanical resonator comprises four masses; each embodiment having a simple degenerate pair of in-plane vibration modes. |
| FILED | Thursday, March 09, 2006 |
| APPL NO | 11/371596 |
| ART UNIT | 3729 — Manufacturing Devices & Processes, Machine Tools & Hand Tools Group Art Units |
| CURRENT CPC | Metal working 029/595 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402264 | Ounaies et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | The United States of America as represented by the Administrator of the National Aeronautics and Space Administration (Washington, District of Columbia) |
| INVENTOR(S) | Zoubeida Ounaies (College Station, Texas); Cheol Park (Yorktown, Virginia); Joycelyn S. Harrison (Hampton, Virginia); Nancy M. Holloway (White Marsh, Virginia); Gregory K. Draughon (Hampton, Virginia) |
| ABSTRACT | An electroactive sensing or actuating material comprises a composite made from a polymer with polarizable moieties and an effective amount of carbon nanotubes incorporated in the polymer for a predetermined electomechanical operation of the composite when such composite is affected by an external stimulus. In another embodiment, the composite comprises a third component of micro-sized to nano-sized particles of an electroactive ceramic that is also incorporated in the polymer matrix. The method for making the three-phase composite comprises either incorporating the carbon nanotubes in the polymer matrix before incorporation of the particles of ceramic or mixing the carbon nanotubes and particles of ceramic together in a solution before incorporation in the polymer matrix. |
| FILED | Thursday, March 03, 2005 |
| APPL NO | 11/076460 |
| ART UNIT | 1796 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Compositions 252/511 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07403113 | Moon et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | California Institute of Technology (Pasadena, California); HRL Laboratories, LLC. (Malibu, California); The United States of America as represented by the Secretary of the Navy (Washington, District of Columbia) |
| INVENTOR(S) | Jeong-Sun Moon (Moorpark, California); Nicholas Prokopuk (Ridgecrest, California); Kyung-Ah Son (Moorpark, California) |
| ABSTRACT | A system for detecting chemical/biological substances and a detection method. The system comprises a plurality of sensing units or nodes and a radiofrequency link. Each unit has several sensors with different sensing curves. Each sensor is able to transmit information related to the sensed substance on a specific frequency. The sensors preferably comprise AlGaN/GaN high electron mobility transistors. |
| FILED | Wednesday, May 11, 2005 |
| APPL NO | 11/128110 |
| ART UNIT | 2612 — Computer Graphic Processing, 3D Animation, Display Color Attribute, Object Processing, Hardware and Memory |
| CURRENT CPC | Communications: Electrical 340/539.220 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Commerce (DOC)
| US 07402253 | van Leeuwen et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Nutech 03, Inc. (Arlington, Virginia) |
| INVENTOR(S) | Johannes van Leeuwen (Story, Iowa); Michael D. Jennings (Ellicott City, Maryland); Richard A Mueller (Olmsted Falls, Ohio); Jack H. Robinson (Clifton, Virginia) |
| ABSTRACT | A method and system of ozone treatment diverts a portion of water from a flow of water in a conduit; injects an ozone-containing gas into the portion to provide an ozonated portion; recombines the ozonated portion with the flow of water in the conduit; and controls and regulates the diverted portion to provide a minimum diverted portion flow rate according to flow in the conduit and proportion of ozone in the injected gas. |
| FILED | Thursday, September 15, 2005 |
| APPL NO | 11/226359 |
| ART UNIT | 1797 — Food, Analytical Chemistry, Sterilization, Biochemistry, Electrochemistry |
| CURRENT CPC | Liquid purification or separation 210/760 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402681 | Ong et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Xerox Corporation (Norwalk, Connecticut) |
| INVENTOR(S) | Beng S. Ong (Mississauga, Canada); Yu Qi (Oakville, Canada); Yiliang Wu (Mississauga, Canada); Yuning Li (Mississauga, Canada) |
| ABSTRACT | A compound composed of a plurality of optionally substituted indolocarbazole moieties which are the same or different from each other. |
| FILED | Monday, June 27, 2005 |
| APPL NO | 11/167512 |
| ART UNIT | 1625 — Organic Chemistry |
| CURRENT CPC | Organic compounds 548/417 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Department of Agriculture (USDA)
| US 07402735 | Browse et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Washington State University Research Foundation (Pullman, Washington) |
| INVENTOR(S) | John A. Browse (Palouse, Washington); James G. Wallis (Moscow, Idaho); Jennifer L. Watts (Moscow, Idaho) |
| ABSTRACT | The amino acid and nucleic acid sequences of a Δ5-desaturase enzyme and a Δ8-desaturase enzyme are disclosed. The nucleic acid sequences can be used to design recombinant DNA constructs and vectors. These vectors can then be used to transform various organisms, including for example, plants and yeast. The transformed organisms will then produce polyunsaturated fatty acids. The amino acid sequences are useful for generating enzyme-specific antibodies that are useful for identifying the desaturases. |
| FILED | Tuesday, October 26, 2004 |
| APPL NO | 10/975692 |
| ART UNIT | 1638 — Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry |
| CURRENT CPC | Multicellular living organisms and unmodified parts thereof and related processes 8/298 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Small Business Administration (SBA)
| US 07402421 | Julien et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Kosan Biosciences, Inc. (Hayward, California) |
| INVENTOR(S) | Bryan Julien (Oakland, California); Leonard Katz (Oakland, California); Chaitan Khosla (Palo Alto, California); Li Tang (Foster City, California); Rainer Ziermann (San Mateo, California) |
| ABSTRACT | Recombinant nucleic acids that encode all or a portion of the epothilone polyketide synthase (PKS) are used to express recombinant PKS genes in host cells for the production of epothilones, epothilone derivatives, and polyketides that are useful as cancer chemotherapeutics, fungicides, and immunosuppressants. |
| FILED | Tuesday, May 18, 2004 |
| APPL NO | 10/849462 |
| ART UNIT | 1656 — Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes |
| CURRENT CPC | Chemistry: Molecular biology and microbiology 435/252.300 |
| VIEW PATENT | @ USPTO: Full Text PDF |
Government Rights Acknowledged
| US 07402657 | Gerard et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) |
| INVENTOR(S) | Craig J. Gerard (Dover, Massachusetts); Norma P. Gerard (Dover, Massachusetts); Charles R. Mackay (Watertown, Massachusetts); Paul D. Ponath (Boston, Massachusetts); Theodore W. Post (Newton, Massachusetts); Shixin Qin (Lexington, Massachusetts) |
| ABSTRACT | The present invention relates to isolated and/or recombinant C-C Chemokine Receptor 3 (CKR-3, CCR3) proteins or polypeptides. |
| FILED | Wednesday, August 31, 2005 |
| APPL NO | 11/216610 |
| ART UNIT | 1646 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/350 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US 07402659 | Pandey et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Whitehead Institute for Biomedical Research (Cambridge, Massachusetts); The Government of the United States of America (Rockville, Maryland); Health Research Inc., Roswell Park Division (Buffalo, New York); University of Washington (Seattle, Washington) |
| INVENTOR(S) | Akhilesh Pandey (Malden, Massachusetts); Katsutoshi Ozaki (Rockville, Massachusetts); Heinz Baumann (Buffalo, New York); Steven D. Levin (Seattle, Washington); Andrew G. Farr (Seattle, Washington); Warren J. Leonard (Bethesda, Massachusetts); Harvey F. Lodish (Brookline, Massachusetts) |
| ABSTRACT | The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides. |
| FILED | Monday, February 07, 2005 |
| APPL NO | 11/052527 |
| ART UNIT | 1647 — Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology |
| CURRENT CPC | Chemistry: Natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 530/351 |
| VIEW PATENT | @ USPTO: Full Text PDF |
| US PP19043 | Anderson et al. |
|---|---|
| FUNDED BY |
|
| APPLICANT(S) | |
| ASSIGNEE(S) | Regents of the University of Minnesota (St. Paul, Minnesota) |
| INVENTOR(S) | Neil O. Anderson (St. Paul, Minnesota); Peter Ascher (Bowler, Wisconsin) |
| ABSTRACT | A new cultivar of chrysanthemum, ‘95-169-8’, characterized by it's frost tolerant quadriplex daisy-type inflorescences with red ray florets and bright yellow disk florets, its vigorous shrub-like growth habit after two years of growth, its tight cushion plant form attained without pinching, and its good garden performance and winter hardiness. |
| FILED | Tuesday, June 12, 2007 |
| APPL NO | 11/811768 |
| ART UNIT | 1661 — Plants |
| CURRENT CPC | Plants PLT/286 |
| VIEW PATENT | @ USPTO: Full Text PDF |
How To Use This Page
THE FEDINVENT PATENT DETAILS PAGE
Each week, FedInvent analyzes newly granted patents and published patent applications whose origins lead back to funding by the US Federal Government. The FedInvent Patent Details page is a companion to the weekly FedInvents Patents Report.
This week's information is published in the FedInvent Patents report for Tuesday, July 22, 2008.
The FedInvent Weekly Patent Details Page contains a subset of patent information to provide a deeper dive into the week’s taxpayer-funded patents to help the reader better understand where a patent fits in the federal innovation ecosphere.
HOW IS THE INFORMATION ORGANIZED?
Patents are organized by the funding agency. Within each group, the patents are organized in numeric order. A patent funded by more than one agency will appear in the section of each of the agencies that funded the research and development that resulted in the invention. This approach gives the reader a complete view of the department or agency activity for the week.
WHAT INFORMATION WILL I FIND?
THE PANEL
There is a panel for each patent that contains the patent number and the title of the patent. When you click the panel, it opens to reveal the following information:
FUNDED BY
The agencies that funded the grants, contracts, or other research agreements that resulted in the patent. FedInvent includes as much information on the source of the funding as possible. The information is presented in a hierarchy going from the Federal Department down to the agencies, subagencies, and offices that funded the work. Here are two examples:
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Department of Defense (DOD)
Defense Advanced Research Projects Agency (DARPA)
Army Research Office (ARO)
We do our best to provide detailed information about the funding. In some cases, the patent only reports limited information on the origins of the funding. FedInvents presents what it can confirm. We add the patents without the information required by the Bayh-Dole Act to our list of patents worthy of further investigation.
APPLICANT(S) and ASSIGNEES
FedInvent includes both the Applicants and the Assignees because having both provides more information about where the inventive work was done and by what organizations. Many organizations — universities, corporations, and federal agencies — standardize the Assignee/Owner information by the time a patent is granted. In the case of federal patents, many of the patents use the agency headquarters information for patent assignment.
Showing just the headquarters address would make Washington, DC the epicenter of all taxpayer-funded research and development. Providing both the applicant information and the assignee information provides a more accurate picture of where important taxpayer funded innovation is happening in America. Here are two examples from two different patents:
APPLICANT: U.S. Army Research Laboratory, Adelphi, MD
ASSIGNEE: The United States of America as represented by the Secretary of the Army Washington, DC
APPLICANT: Optech Ventures, LLC (Torrance, California)
ASSIGNEE(S): The Regents of the University of California (Oakland, California); Optech Ventures, LLC (Torrance, California)
INVENTOR(S)
The inventors appear in the same order as they appear on the patent. FedInvents presents the names in first name/last name order because they are easier to read than the last name/first name order of the names on the USPTO patent documents.
ABSTRACT
The abstract as it appears on the patent.
FILED
The date of the patent application including the day of the week.
APPL NO
This is the patent application serial number. If you’d like to learn more about how application serial numbers work you can go to the Lists Page.
ART UNIT
Patent data includes the Art Unit where a patent was examined. (The Art Unit isn’t available for published patent applications.) The Art Unit provides insight into what group of patent examiners prosecuted the patent application and the subject matter that the examiners work on. For example:
3793 — Medical Instruments, Diagnostic Equipment, and Treatment Devices
You can learn more about ART UNITS on the FedInvent Patents Weekly panel called About Tech Center or you can find information on the FedInvent Lists Page.
CURRENT CPC
Current CPC provides a list of the Cooperative Patent Classification symbols assigned to the patent. These are the CPC symbols assigned at the time the patent was granted.
The FedInvent Project is a patent classification maximalist endeavor or put another way, we believe that more you understand about patent classification the more you'll learn about the nature of the invention and the types of work that the federal government is funding.
The symbol presented in BOLD is the symbol identified as the "first" classification which is the most relevant classification on the patent. The date that follows the symbol is the date of the most recent revision to the art classed there.
- A61B 1/149 (20130101)
- A61B 1/71 (20130101)
- A61B 1/105 (20130101)
The CPC symbols match the classifications found on the PDF version of the patent. Over time, the classifications on the full-text version of the patent change to reflect how USPTO organizes patent art to support its examiners. The two sets of CPCs don’t always match.
VIEW PATENT
As of June 2021, we include two ways to view a patent at USPTO. FedInvent provides a link to the Full-Text Version of the patent and a link to the PDF version of the patent.
HOW DO I FIND A SPECIFIC PATENT ON A PAGE?
You can use the Command F or Control F to find a specific patent you are interested in.
HOW DO I GET HERE?
You navigate to the details of a patent by clicking the information icon that follows a patent on the FedInvent Patents Weekly Report.
You can also reach this page using the weekly page link that looks like this:
https://wayfinder.digital/fedinvent/patents-2008/fedinvent-patents-20080722.html
Just update the date portion of the URL. Tuesdays for patents. Thursdays for pre-grant publication of patent applications.
Download a copy of the How To Use This Page